Concepedia

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women

Simone J.M. Neele, Reinder Evertz, G De Valk-De Roo, Jan C. Roos, J. C. Netelenbos

Bone · 2002 · 101 citations · 31 references

DOI

Concepts

References

31

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.9K citations

, , +12

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

, , +17

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

Pierre D. Delmas, Nina H. Bjarnason, Bruce Mitlak et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

, , +17

Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

Edward G. Lufkin, Heinz W. Wahner, W. Michael O’Fallon et al. · Annals of Internal Medicine · 1992 · 820 citations

, , +17

BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY

Claus Christiansen, Merete Sanvig Christensen, Ib Transbøl · The Lancet · 1981 · 593 citations

, , +9